USSTOCK.TODAY
Market Closed
Log in Sign up

Raymond James Selects 4 Top Healthcare Picks with Anticipated Clinical Results

Investing.com ·

RJF Raymond James Financial Inc
$158.60 +0.86%
View chart & analysis →
DYN DYN +2.50%TRVI TRVI -2.40%
  1. 1Raymond James has selected healthcare sector stocks with clinical trial results and promising drug development programs.
  2. 2Dyne Therapeutics awaits results from the z-rostudirsen (DYNE-251) registration expansion cohort in 4Q25.
  3. 3Tyra Biosciences has major catalysts in 2026 for two indications with market potential exceeding $1 billion each.

So what's the key point?

Raymond James has chosen four healthcare companies expected to develop effective drugs. Companies such as Dyne Therapeutics and Tyra Biosciences are drawing attention.

Source Investing.com · View original ↗

Related 3-line summaries

Raymond James raises jet fuel outlook, cuts airline estimates, upgrade Allegiant to Strong Buy Investing.com +2 · Aug 24Interactive Brokers beats Q2 estimates GuruFocus.com +1 · Jul 22Dyne Therapeutics slides 9% on $375M marketed equity offering Investor's Business Daily +1 · Jul 22
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news